Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials

The main objective of this post hoc analysis is to compare the magnitude of the immune response to HPV31/33/45/52 and 58 after a dose of 9vHPV vaccine given to naïve (previously unvaccinated) subjects and subjects previously vaccinated with a dose of 2vHPV or 4vHPV vaccine. Results from two clinical...

Full description

Bibliographic Details
Main Authors: Chantal Sauvageau, Gitika Panicker, Elizabeth R. Unger, Gaston De Serres, John Schiller, Manale Ouakki, Vladimir Gilca
Format: Article
Language:English
Published: Taylor & Francis Group 2020-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human papillomavirus
vaccination
immunogenicity
clinical trial
Online Access:http://dx.doi.org/10.1080/21645515.2019.1669413

Internet

http://dx.doi.org/10.1080/21645515.2019.1669413

Similar Items